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Autoimmune disease is typically defined as an aberrant response of lymphocytes to self 
antigens that ultimately leads to tissue damage. Reporting in Immunity, Green et al. (2007) 
now show that mice lacking α-mannosidase II develop an autoimmune disease similar to 
lupus. Remarkably, this illness is precipitated by an innate immune response to altered self 
glycans that mimic molecular patterns found on pathogens.Autoimmune diseases, including 
systemic lupus erythematosus (SLE), 
juvenile (type 1) diabetes, rheuma-
toid arthritis, Crohn’s disease, and 
over 80 others, are generally thought 
to be triggered by aggressive 
responses of the adaptive immune 
system to self antigens, resulting 
in tissue damage and pathological 
sequelae (Davidson and Diamond, 
2001). Yet, the molecular and cellular 
mechanisms that underlie the initia-
tion and progression of autoimmune 
diseases are still poorly understood. 
In work recently published in Immu-
nity, Green et al. (2007) report on a 
mouse model of an autoimmune dis-
ease similar to lupus that does not 
require the adaptive immune system 
but is instead triggered by the innate 
immune response.
For many autoimmune diseases, 
the key roles of T cells and B cells 
are well documented and are evident 
in the success of T cell (anti-CD3) 
and B cell (anti-CD20) depletion 
strategies for the treatment of diabe-
tes and rheumatoid arthritis, respec-
tively. Research continues to reveal 
new insights into the respective roles 
of the humoral and cell-mediated 
arms of adaptive immunity and the 
distinct roles of T cell subsets, for 
example Th17 cells, in autoimmunity 
(Bettelli et al., 2007).
Dendritic cells, macrophages, and 
other myeloid cells also play impor-
tant roles in autoimmune diseases, 
both as antigen presenting cells and as effector cells that mediate tissue 
damage (Davidson and Diamond, 
2001; Geijtenbeek et al., 2004; Men-
sah-Brown et al., 2006; Ohtsubo and 
Marth, 2006). Because these cells 
are also major mediators of innate 
immunity, interest has surfaced 
in the potential for innate immune 
responses to contribute to disease 
pathology. Receptors that mediate 
innate immune responses such as 
Toll-like receptors (TLRs) and gly-
can-specific C-type lectin recep-
tors (CLRs) that recognize patho-
gen-associated molecular patterns 
(PAMPs) have been implicated in 
autoimmune disease mechanisms, 
both directly through recognition of 
self ligands and indirectly through 
the regulation of immune homeosta-
sis (Geijtenbeek et al., 2004; Mar-
shak-Rothstein and Rifkin, 2007; 
Robinson et al., 2006).
In light of the roles of myeloid cells 
as effector cells in disease progres-
sion, can “autoimmune” disease 
occur in the absence of adaptive 
immunity? The case of the moth-
eaten mouse mutant suggests that it 
can (Yu et al., 1996). Motheaten mice 
are deficient in hematopoietic cell 
phosphatase. They exhibit a severe 
autoimmune-like disease character-
ized by alopecia (hence the “moth-
eaten” appearance) inflamed paws, 
high titers of autoimmune antibodies, 
deposition of immune complexes in 
kidney and other tissues, and short-
ened lifespan resulting from pneu-Cell 130, Amonia associated with accumulation 
of leukocytes in the lungs. Although 
this mouse was considered a model 
of classic autoimmune disease, Yu 
et al. (1996) crossed the mice defi-
cient in the hematopoietic cell phos-
phatase with mice lacking recombi-
nase-activating gene-1 (RAG-1) that 
are deficient in production of T and 
B cells. They found that the disease 
progressed normally in the absence 
of an adaptive immune response 
(Yu et al., 1996). Although the mice 
lacked the high titers of antibod-
ies and deposition of immune com-
plexes in tissues, they exhibited all 
of the other symptoms of the dis-
ease, including shortened lifespan. 
Although the detailed mechanism of 
the initiation and progression of the 
disease was not defined, it was con-
cluded that the autoimmune disease 
of motheaten mice was mediated by 
an aggressive response of macro-
phages and other myeloid cells.
Now, Green et al. (2007) describe 
an SLE-like disease in mice defi-
cient in the enzyme α-mannosidase 
II (αM-II) that appears to be driven 
solely by a mechanism involving 
an innate immune response (Green 
et al., 2007). Aging αM-II null mice 
acquire symptoms characteristic 
of SLE and lupus nephritis includ-
ing high titers of anti-DNA anti-
body, immunoglobulin deposition in 
the kidney and other tissues, glo-
merulonephritis, renal dysfunction, 
and kidney failure. To assess the ugust 24, 2007 ©2007 Elsevier Inc. 589
role of antibodies and the adaptive 
immune system in the pathology of 
the disease, mice lacking αM-II were 
crossed with RAG-1-deficient mice, 
which are incapable of producing T 
and B lymphocytes. Surprisingly, the 
absence of an adaptive immune sys-
tem exacerbated and accelerated 
the onset of the SLE-like disease, 
demonstrating that the initiation and 
propagation of the disease was inde-
pendent of an immune response to 
self antigen. High dose intravenous 
immunoglobulin actually reduced 
the disease pathology, suggesting 
that the adaptive immune system 
had a moderating effect. These and 
supporting results led to the conclu-
sion that the disease is mediated by 
an innate immune response resulting 
from αM-II deficiency.
So, what is the link between αM-
II deficiency and induction of an 
autoimmune-like disease? The αM-
II enzyme carries out a key step in 
the biosynthesis of N-linked glycans 
of glycoproteins and is constitu-
tively expressed in most cell types. 
Its function is to complete the trim-
ming of mannose residues from the 
high-mannose type N-linked glycans 
of newly synthesized glycoproteins, 
prior to addition of terminal “com-
plex” sugars to the three mannose 
core structure (Figure 1A). Without 
this step, the cell makes “hybrid” 
structures that contain two additional 
mannose residues on one branch of 
the N-linked glycans. The deficiency 
of αM-II has a minimal effect on gly-
can biosynthesis in most cell types 
because another mannosidase, αM-
IIx, can compensate for the absence 
of αM-II. In cells deficient in both 
αM-II and αM-IIx, glycoproteins are 
produced with the aberrant hybrid 
type structures. In αM-II null mice, 
hybrid structures are increased in 
serum glycoproteins and are abun-
dantly expressed on kidney cells and 
cells of the erythroid lineage.
Green et al. provide evidence that 
the abnormal presence of hybrid 
glycoprotein structures acts as a 
trigger for the induction of an innate 
immune response mediated by 
members of the C-type lectin fam-
ily that are specific for mannose. 
The serum mannose binding lectins 
(MBL-A and MBL-B) are soluble lec-
tins that mediate innate immunity 
to pathogenic bacteria and fungi 
that express mannose-containing 
glycans. The cell surface macro-
phage mannose receptor (MMR) is 
similarly thought to participate in 
figure 1. self Glycans Trigger an Innate Immune Response in Mice Lacking αM-II
(A) α-mannosidase II (αM-II) participates in the normal processing of N-linked glycans from the 
high-mannose type (left) to complex type (top right). In αM-II null mice, most cell types process 
glycans normally due to a compensating enzyme, αM-IIx. However, αM-IIx is not expressed by 
erythroid cells or kidney mesangial cells, resulting in “hybrid” type glycans with terminal mannose 
residues (bottom right).
(B) Recognition of hybrid type glycans by macrophage mannose receptor (MMR) on mesangial 
cells, and binding of mannose binding lectins (MBL) to hybrid type glycans on membrane gly-
coproteins, is proposed to induce expression of monocyte chemoattractant protein-1 (MCP-1). 
This results in recruitment of activated macrophage effector cells, which then mediate tissue 
damage that leads to an automimmune-like disease with features similar to systemic lupus ery-
thematosus.590 Cell 130, August 24, 2007 ©2007 Elsevier Inc.innate immune responses, and its 
expression has been documented 
on kidney mesangial cells (Linehan 
et al., 1999; Robinson et al., 2006). 
In αM-II null mice, MBL lectins are 
deposited on kidney glomeruli that 
express high levels of mannose-con-
taining glycans. Mesangial cells also 
express increased levels of MMR, 
which can bind mannose-contain-
ing ligands in the serum. Elevated 
levels of monocyte chemoattractant 
protein-1 (MCP-1), produced by acti-
vated mesangial cells, account for 
the influx of activated macrophages. 
From these findings, Green et al. pro-
pose that the aberrantly expressed 
mannose-containing glycans in αM-
II null mice act as a trigger for an 
innate immune response mediated 
by mannose-specific C-type lec-
tins programmed to recognize high 
mannose glycans as a PAMP. This 
results in production of MCP-1 and 
recruitment and activation of mac-
rophages. The macrophages then 
serve as the primary effector cells 
that cause tissue damage and loss 
of kidney function.
Which came first, the chicken or 
the egg? Or, in this case, the adap-
tive or innate immune response? 
The demonstration of anti-DNA 
antibodies in serum of αM-II null 
mice led the investigators to initially 
conclude that the SLE-like disease 
was caused by an aberrant adaptive 
immune response to self antigens. In 
fact, this now appears secondary to 
the primary disease mechanism. The 
surprisingly minor roles of autoanti-
bodies in the disease mechanisms 
of the motheaten mice and αM-II 
null mice are strikingly similar. The 
take-home lesson may be to keep an 
open mind with respect to the roles 
of the adaptive and innate immune 
responses in mechanisms of auto-
immune disease.
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